ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.93
      0.17%
      Bitcoin
      65,114.45
      -0.04%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Atara Biotherapeutics Inc (ATRA)

      7. Atara Biotherapeutics Inc (ATRA) News

      ATRA

      Atara Biotherapeutics (ATRA)

      Atara Biotherapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRA
      DateTimeSourceHeadlineSymbolCompany
      08/01/20224:01PMBusiness WireAtara Biotherapeutics to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022NASDAQ:ATRAAtara Biotherapeutics Inc
      07/25/20226:25AMTipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:ATRAAtara Biotherapeutics Inc
      07/22/20224:07PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ATRAAtara Biotherapeutics Inc
      07/20/20222:35PMTipRanksMizuho Securities Thinks Atara Biotherapeutics’ Stock is Going to RecoverNASDAQ:ATRAAtara Biotherapeutics Inc
      07/12/20224:30PMBusiness WireAtara Biotherapeutics Announces Completion of the ATA188 Phase 2 EMBOLD Study Interim Analysis in Patients with Progressive MSNASDAQ:ATRAAtara Biotherapeutics Inc
      07/12/20221:50PMTipRanksAtara Biotherapeutics (ATRA) Gets a Buy Rating from Mizuho SecuritiesNASDAQ:ATRAAtara Biotherapeutics Inc
      07/07/20223:15PMTipRanksMizuho Securities Sticks to Its Buy Rating for Atara Biotherapeutics (ATRA)NASDAQ:ATRAAtara Biotherapeutics Inc
      07/06/20224:01PMBusiness WireAtara Biotherapeutics to Announce Completion of ATA188 Phase 2 EMBOLD Study Interim Analysis on Tuesday, July 12, 2022NASDAQ:ATRAAtara Biotherapeutics Inc
      07/01/20227:57PMBusiness WireAtara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/29/20224:15AMTipRanksMizuho Securities Thinks Atara Biotherapeutics’ Stock is Going to RecoverNASDAQ:ATRAAtara Biotherapeutics Inc
      06/27/20224:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/27/20224:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/27/20224:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/27/20224:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/27/20224:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/27/20224:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/27/20224:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/24/20224:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/10/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/04/20229:00AMBusiness WireAtara Biotherapeutics Announces First Clinical Data from Ongoing Tab-cel® European Multicenter Expanded Access Program (EAP) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting and Update on Tab-cel EMA Regulatory ProgressNASDAQ:ATRAAtara Biotherapeutics Inc
      06/03/20224:01PMBusiness WireAtara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/23/20226:28AMTipRanksH.C. Wainwright Thinks Atara Biotherapeutics’ Stock is Going to RecoverNASDAQ:ATRAAtara Biotherapeutics Inc
      05/19/20227:45PMTipRanksAtara Biotherapeutics (ATRA) Receives a Buy from Mizuho SecuritiesNASDAQ:ATRAAtara Biotherapeutics Inc
      05/19/20225:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/19/20225:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/19/20225:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/19/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/19/20224:01PMBusiness WireAtara Biotherapeutics Provides Update on Strategic Collaboration with BayerNASDAQ:ATRAAtara Biotherapeutics Inc
      05/08/202210:31PMTipRanksStifel Nicolaus Thinks Atara Biotherapeutics’ Stock is Going to RecoverNASDAQ:ATRAAtara Biotherapeutics Inc
      05/06/20224:01PMBusiness WireAtara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ATRA